Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Barber Daniel
President and CEO at Aquestive Therapeutics. Filing since 10 Dec 2018.
CIK 0001742266
Company
Date
Role
Action
Shares
Amount
Of holding
AQST
Aquestive Therapeutics, Inc.
15 Sep 2026
President and CEO
Sold on a plan
25,000
$120.49K
3.7%
AQST
Aquestive Therapeutics, Inc.
17 Aug 2026
President and CEO
Sold on a plan
25,000
$107.17K
4.1%
AQST
Aquestive Therapeutics, Inc.
16 Jul 2026
President and CEO
Sold on a plan
20,369
$81.51K
3.2%
AQST
Aquestive Therapeutics, Inc.
15 Jul 2026
President and CEO
Sold on a plan
4,631
$18.68K
0.7%
AQST
Aquestive Therapeutics, Inc.
15 Jun 2026
President and CEO
Sold on a plan
25,000
$104.01K
3.8%
AQST
Aquestive Therapeutics, Inc.
15 May 2026
President and CEO
Sold on a plan
8,257
$35.41K
1.2%
AQST
Aquestive Therapeutics, Inc.
10 Mar 2026
President and CEO
Sold at will
180,677
$753.97K
15.2%
AQST
Aquestive Therapeutics, Inc.
26 Sep 2025
President and CEO
Sold on a plan
91,343
$551.19K
9.0%
AQST
Aquestive Therapeutics, Inc.
19 Sep 2025
President and CEO
Sold on a plan
400
$2.40K
0.0%
AQST
Aquestive Therapeutics, Inc.
8 Jun 2022
Chief Executive Officer
Bought
91,743
$88.07K
90.0%
AQST
Aquestive Therapeutics, Inc.
27 Aug 2019
SVP-Chief Operating Officer
Bought
2,000
$7.98K
2.0%
AQST
Aquestive Therapeutics, Inc.
10 Dec 2018
SVP-Chief Strategy/Dev Officer
Bought
1,000
$8.00K
1.0%
12 decisions on file.
